ChromaDex Corporation (CDXC) had a rough trading day for Thursday October 10 as shares tumbled 8.62%, or a loss of $-0.3 per share, to close at $3.18. After opening the day at $3.50, shares of ChromaDex Corporation traded as high as $3.50 and as low as $2.82. Volume was 785,424 shares over 3,288 trades, against an average daily volume of n/a shares and a total float of 59.57 million.
As a result of the decline, ChromaDex Corporation now has a market cap of $189.42 million. In the last year, shares of ChromaDex Corporation have traded between a range of $4.95 and $2.79, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.
ChromaDex Corp is a science-based integrated nutraceutical company. The products of the company are devoted at improving human immune function. The company produces dietary supplements, skin care, pharmaceutics, and animal health products.
ChromaDex Corporation is based out of Los Angeles, CA and has some 100 employees. Its CEO is Robert N. Fried.
ChromaDex Corporation is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
